Antiphospholipid syndrome
an-tee-fos-fo-LIP-id SIN-drohm
Also known as: APS, Hughes syndrome
At a Glance
What is Antiphospholipid syndrome?
Antiphospholipid syndrome is an autoimmune disorder where the body's immune system mistakenly attacks normal proteins in the blood. This condition primarily affects the cardiovascular and nervous systems, leading to an increased risk of blood clots. It is caused by the presence of antiphospholipid antibodies that disrupt normal blood clotting processes. Over time, this can lead to complications such as deep vein thrombosis, stroke, or recurrent miscarriages. Early symptoms might include unexplained blood clots or pregnancy complications, while later symptoms can involve organ damage due to impaired blood flow. Early diagnosis is crucial to prevent severe complications and manage the risk of thrombosis effectively. The condition can significantly impact family life, especially in cases of pregnancy loss or chronic health issues. Prognosis varies, with some individuals managing well with treatment, while others may experience recurrent issues. Daily life for those affected often involves regular monitoring and medication to manage clotting risks. Lifestyle adjustments, such as avoiding smoking and maintaining a healthy weight, are also important. Support from healthcare providers and family is essential for managing the condition. With proper treatment, many individuals can lead relatively normal lives, though ongoing vigilance is necessary.
Medical Definition
Antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies that lead to hypercoagulability, resulting in recurrent venous or arterial thrombosis and pregnancy-related complications. Pathologically, it involves the formation of thrombi due to antibody-mediated interference with phospholipid-binding proteins. Histological findings may show evidence of thrombosis in affected tissues, with no specific inflammatory changes. The classification of APS is based on clinical criteria, including vascular thrombosis and pregnancy morbidity, alongside laboratory criteria involving specific antibody tests. Epidemiologically, APS is more common in women and often coexists with other autoimmune diseases, such as systemic lupus erythematosus. The disease course can be variable, with some individuals experiencing recurrent thrombotic events while others remain asymptomatic with appropriate management.
Antiphospholipid syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Thrombosis manifests clinically as the formation of blood clots in veins or arteries, leading to potential complications such as deep vein thrombosis or stroke. The biological mechanism involves the presence of antiphospholipid antibodies that promote coagulation. Over time, recurrent thrombotic events can occur, increasing the risk of organ damage. This affects daily life by necessitating long-term anticoagulation therapy to prevent further clots, which requires regular monitoring and lifestyle adjustments.
Recurrent pregnancy loss is characterized by multiple miscarriages, often occurring in the first trimester. This is caused by antiphospholipid antibodies interfering with placental function and blood flow. Over time, the risk of miscarriage remains high without appropriate treatment. It affects daily life by causing emotional distress and necessitating specialized medical care during pregnancy to improve outcomes.
Livedo reticularis presents as a mottled, purplish skin discoloration, typically on the legs. It is caused by impaired blood flow due to small vessel thrombosis. This condition may persist or fluctuate over time, sometimes indicating more severe underlying vascular issues. It affects daily life by causing cosmetic concerns and potential discomfort, and it may require medical evaluation to assess for systemic involvement.
Common
Neurological symptoms can include headaches, migraines, or even transient ischemic attacks. These occur due to microthrombi affecting cerebral circulation. Symptoms may be episodic or progressive, depending on the extent of vascular involvement. They impact daily life by potentially impairing cognitive function and requiring medical management to prevent progression.
Cardiac valve abnormalities manifest as valvular thickening or dysfunction, detectable via echocardiography. This is caused by the deposition of immune complexes and thrombi on the valves. Over time, these abnormalities can progress to significant valvular heart disease. They affect daily life by potentially leading to heart failure symptoms and necessitating regular cardiac monitoring and possible surgical intervention.
Thrombocytopenia is characterized by a low platelet count, which can lead to increased bleeding risk. It is caused by the immune-mediated destruction of platelets. Over time, it can fluctuate, sometimes requiring treatment to prevent bleeding complications. It affects daily life by necessitating careful monitoring of platelet levels and avoidance of activities that increase bleeding risk.
Less Common
Renal impairment can manifest as proteinuria or elevated creatinine levels, indicating kidney dysfunction. This occurs due to thrombotic microangiopathy affecting renal blood vessels. Over time, it can progress to chronic kidney disease if not managed effectively. It affects daily life by requiring dietary and lifestyle modifications and possibly leading to dialysis if severe.
Skin ulcers present as painful, non-healing sores, often on the lower extremities. They are caused by impaired blood flow and small vessel thrombosis. Over time, these ulcers can become chronic and resistant to treatment. They affect daily life by causing pain, limiting mobility, and requiring ongoing wound care and medical attention.
What Causes Antiphospholipid syndrome?
Antiphospholipid syndrome (APS) is primarily associated with the presence of antiphospholipid antibodies rather than a specific genetic mutation, thus no single causative gene has been identified. The antibodies target phospholipid-binding proteins, such as beta-2 glycoprotein I, which are involved in the coagulation pathway. In APS, these antibodies disrupt the normal function of these proteins, leading to hypercoagulability. The immediate molecular consequence is the activation of endothelial cells and platelets, promoting thrombosis. This dysfunction affects the coagulation cascade, resulting in increased clot formation. The immune response is characterized by the production of autoantibodies, which can lead to systemic inflammation. Neuroinflammation may occur when clots form in cerebral vessels, potentially causing stroke or transient ischemic attacks. White matter lesions can develop due to repeated ischemic events, contributing to neurological symptoms. Symptoms appear in a pattern related to the vascular territories affected by thrombosis, such as recurrent miscarriages, deep vein thrombosis, or stroke. Disease severity varies between patients due to factors like the specific antibody profile, genetic predispositions, and environmental triggers. Some patients may experience catastrophic antiphospholipid syndrome, a severe form with rapid organ failure. The variability in clinical presentation is also influenced by the presence of other autoimmune conditions, such as systemic lupus erythematosus. The interplay between genetic factors and immune system dysregulation contributes to the heterogeneity of APS. Understanding the precise mechanisms of antibody-mediated damage is crucial for developing targeted therapies. Ongoing research aims to elucidate the pathways involved in APS to improve diagnosis and treatment strategies.
How is Antiphospholipid syndrome Diagnosed?
Typical age of diagnosis: Antiphospholipid syndrome is typically diagnosed in adults between the ages of 30 and 50, often after a thrombotic event or recurrent pregnancy loss. Diagnosis may occur earlier in individuals with a family history of autoimmune disorders or in those presenting with unexplained clinical symptoms consistent with APS.
Clinicians look for a history of thrombosis or pregnancy complications, such as recurrent miscarriages or preterm births. Important history elements include previous thrombotic events, autoimmune disease symptoms, and family history of similar conditions. Physical examination may reveal signs of livedo reticularis or other skin manifestations. This step helps determine if further testing for APS is warranted based on clinical suspicion.
Doppler ultrasound is commonly used to detect deep vein thrombosis, while MRI or CT scans may be employed for cerebral or visceral thrombosis. Imaging can reveal vascular occlusions or infarctions, supporting the diagnosis of APS. Findings from imaging studies help confirm the presence of thrombotic events and exclude other causes of similar symptoms. Differential diagnoses such as vasculitis or atherosclerosis are considered based on imaging results.
Specific tests include lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies. These biomarkers are sought to establish the presence of antiphospholipid antibodies. Abnormal results typically show elevated levels of these antibodies on two or more occasions at least 12 weeks apart. Laboratory findings guide the confirmation of APS and the exclusion of other coagulopathies.
Currently, there are no specific genes sequenced for APS as it is not primarily a genetic disorder. However, genetic testing may focus on related autoimmune conditions to identify susceptibility. While genetic results do not confirm APS, they can provide insight into familial patterns of autoimmune diseases. Genetic counseling may be offered to discuss potential risks for family members.
Antiphospholipid syndrome Treatment Options
Anticoagulants such as warfarin or heparin are the mainstay of treatment for APS. They work by inhibiting the coagulation cascade to prevent thrombus formation. Warfarin is commonly used for long-term management, with heparin as an option during pregnancy. Clinical evidence supports their efficacy in reducing thrombotic events in APS patients. Limitations include the need for regular monitoring and potential bleeding risks.
Exercise therapy may include low-impact aerobic exercises and strength training. The goal is to improve circulation and reduce the risk of thrombosis. Sessions are typically conducted 2-3 times a week for 30-60 minutes. Measurable outcomes include improved cardiovascular fitness and reduced incidence of thrombotic events. Long-term benefits include enhanced overall health and reduced APS complications.
Thrombectomy is indicated for acute, life-threatening thrombotic events unresponsive to medical therapy. The procedure involves the surgical removal of a thrombus from a blood vessel. Expected benefits include immediate restoration of blood flow and prevention of tissue damage. Surgical risks include bleeding, infection, and vessel injury. Post-operative care involves anticoagulation therapy and monitoring for recurrence.
The care team typically includes rheumatologists, hematologists, and obstetricians for pregnant patients. Specific interventions include regular monitoring, medication management, and lifestyle counseling. Psychosocial support strategies address the emotional impact of chronic illness. Family education focuses on recognizing symptoms and managing treatment regimens. Long-term monitoring involves regular follow-ups to assess treatment efficacy and adjust care plans.
When to See a Doctor for Antiphospholipid syndrome
- Sudden onset of chest pain or shortness of breath — this could indicate a pulmonary embolism, which is a life-threatening condition requiring immediate medical attention.
- Severe headache with vision changes — this may suggest a stroke, which is a medical emergency needing urgent evaluation and treatment.
- Unexplained swelling or pain in the limbs — this could be a sign of deep vein thrombosis, which can lead to serious complications if not treated promptly.
- Persistent fatigue — this may indicate worsening of the condition or complications, and it is advisable to consult a healthcare provider for further evaluation.
- Recurrent miscarriages — this is a significant symptom of antiphospholipid syndrome and should be discussed with a healthcare provider for appropriate management.
- Unusual skin rashes — these could be indicative of underlying vascular issues related to the syndrome and warrant medical assessment.
- Mild joint pain — monitor for any increase in severity or frequency, and consult a doctor if it worsens.
- Occasional headaches — keep track of triggers and frequency, and seek medical advice if they become more frequent or severe.
Antiphospholipid syndrome — Frequently Asked Questions
Is this condition hereditary?
Antiphospholipid syndrome is not typically considered a hereditary condition, as it does not follow a clear inheritance pattern. The probability of passing it to children is not well-defined, but having a family history may increase risk. De novo mutations are not a known cause of antiphospholipid syndrome. Carrier status does not apply as it is not a genetic disorder in the traditional sense. Genetic counseling is recommended for those with family history to understand potential risks.
What is the life expectancy for someone with this condition?
Life expectancy can vary significantly depending on the age of onset and severity of the condition. Factors such as adherence to treatment and management of risk factors can improve outcomes. Mortality is often related to thrombotic events like strokes or heart attacks. Effective treatment with anticoagulants can significantly enhance survival rates. Patients should have realistic expectations and work closely with healthcare providers to manage the condition.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves clinical evaluation and laboratory tests to detect antiphospholipid antibodies. The time from first symptoms to diagnosis can vary, often taking months due to the complexity of symptoms. Rheumatologists or hematologists are typically consulted for diagnosis. Delayed diagnosis is common due to symptom overlap with other conditions. Confirmation requires persistent positive antibody tests over a 12-week period.
Are there any new treatments or clinical trials available?
Research is ongoing, with promising studies focusing on novel anticoagulants and immune-modulating therapies. Gene therapy is not currently a focus, but biologic treatments are being explored. ClinicalTrials.gov is a resource for finding relevant trials, and patients should discuss options with their doctors. It is important to ask about the potential benefits and risks of participating in trials. New treatments may become available in the next few years, but timelines can vary.
How does this condition affect daily life and activities?
Antiphospholipid syndrome can impact mobility and self-care due to pain or fatigue. Educational and occupational activities may be affected by frequent medical appointments or symptoms. Social and emotional challenges include coping with chronic illness and potential isolation. Family members may experience increased caregiving responsibilities. Supportive therapies and adaptations, such as physical therapy and counseling, can help manage these challenges.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Diagnosis and Management of the Antiphospholipid Syndrome.
Garcia D, Erkan D · N Engl J Med · 2018 · PMID: 29791828
- 2.Antiphospholipid syndrome.
Petri M · Transl Res · 2020 · PMID: 32413497
- 3.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
Miyakis S, Lockshin MD, Atsumi T et al. · J Thromb Haemost · 2006 · PMID: 16420554
- 4.Antiphospholipid syndrome.
Cervera R · Thromb Res · 2017 · PMID: 28262233
- 5.Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities.
Newman TG, Knight JS · Arthritis Rheumatol · 2025 · PMID: 40386969
- 6.Editorial: Primary Antiphospholipid Syndrome.
Serrano A, Cervera R, Gris JC · Front Immunol · 2020 · PMID: 32983139
- 7.The antiphospholipid syndrome.
Fischer MJ, Rauch J, Levine JS · Semin Nephrol · 2007 · PMID: 17336687
- 8.Antiphospholipid syndrome in obstetrics.
Kemp M, Thomas W · Lupus · 2018 · PMID: 30452326
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-06-12